Multi-Target Actions of Flavonoid Derivatives from Mesua ferrea Linn Flower against Alzheimer’s disease Pathogenesis

Authors

Keywords:

flavonoid rhamnosides, Alzheimer’s disease, oxidation, beta amyloid, acetylcholinesterase, molecular docking

Abstract

OBJECTIVE Kaempferol-3-O-rhamnoside (compound 1) and quercetin- 3-O-rhamnoside (compound 2), two flavonoids isolated from Mesua ferrea L. flowers, were examined for their activities related Alzheimer’s disease (AD) pathogenesis including antioxidant, acetylcholinesterase (AChE) inhibition, anti-beta amyloid (Aβ) aggregation and neuroprotection.

METHODS The two flavonoids were isolated from M. ferrea L. flowers using the column chromatography technique. Both compounds were evaluated for their effects on AD pathogenesis, including antioxidant action by ABTS assay, AChE inhibition by Ellman’s method, and anti-Aβ aggregation by thioflavin T (ThT) assay and neuroprotection by cell base assay. To explain the mechanism of AChE inhibition and anti-Aβ aggregation, binding interactions between the test compounds and AChE and Aβ were studied in-silico.

RESULTS Compounds 1 and 2 showed an ability to scavenge ABTS radicals, with IC50 values of 424.57±2.97 and 308.67±9.90 μM, respectively, and to inhibit AChE function with IC50 values of 769.23±6.23 and 520.64±5.94, respectively. ThT assay indicated that both compounds inhibited Aβ aggregation with IC50 values of 406.43±9.95 and 300.69 ±1.18 μM, respectively. The neuroprotection study revealed that the two flavonoids could reduce human neuroblastoma (SH-SY5Y) cell death induced by H2O2. The in-silico study showed that both compounds bound AChE at catalytic anionic and peripheral anionic sites. In addition, the test compounds prevented Aβ aggregation by interacting at the central hydrophobic core, the C-terminal hydrophobic region, and the important residues of Ile41.

CONCLUSIONS Together, the results showed that kaempferol-3-O- rhamnoside and quercetin-3-O- rhamnoside exhibit multiple mechanisms of action that are involved in the pathogenesis of AD including antioxidant, AChE inhibition, anti-Aβ aggregation, and neuroprotection.

References

Alzheimer’s Disease International. World Alzheimer Report 2019-Attitudes to dementia. London: Alzheimer’s Disease International. 2019.

Alzheimer’s Association. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17:327-406.

Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, et al. The cost of Alzheimer’s disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14:483-91.

Hardy JA, Higgins GA. Alzheimer’s disease: The amyloid cascade hypothesis. Science. 1992;256:184-5.

Naseri NN, Wang H, Guo J, Sharma M, Luo W. The complexity of tau in Alzheimer’s disease. Neurosci Lett. 2019;705:183-94.

Yoo JH, Valdovinos MG, Williams DC. Relevance of donepezil in enhancing learning and memory in special populations: A Review of the literature. J Autism Dev Disord. 2007;37:1883–901.

Scrivo R, Vasile M, Bartosiewicz I, Valesini G. Inflammation as “common soil” of the multifactorial diseases. Autoimmun Rev. 2011;10:369-74.

Praticò D. Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows. Ann N Y Acad Sci. 2008:1147:70-8

Rosini M, Simoni E, Bartolini M, Cavalli A, Ceccarini L, Pascu N, et al. Inhibition of acetylcholinesterase, β-Amyloid aggregation, and NMDA receptors in Alzheimer’s disease: a promising direction for the multi-target-directed ligands gold rush. J Med Chem. 2008;51:4381–4.

Švecová M, Ulbrich P, Dendisová M, Matějka P. SERS study of riboflavin on green-synthesized silver nanoparticles prepared by reduction using different flavonoids: What is the role of flavonoid used? Spectrochim Acta A Mol Biomol Spectrosc. 2018;195:236-45.

Bowles D, Lim EK, Poppenberger B, Vaistij FE. Glycosyltransferases of lipophilic small molecules. Annu Rev Plant Biol. 2006;57:567-97.

Tahara S. A journey of twenty-five years through the ecological biochemistry of flavonoids. Biosci Biotechnol Biochem. 2007;71:1387-404.

Li J, Sun M, Cui X, Li C. Protective effects of flavonoids against Alzheimer’s disease: pathological hypothesis, potential targets, and structure–activity relationship. Int J Mol Sci. 2022;23:10020. PubMed PMID: 36077418

Nandy S, Tiwari P. Screening of anti-inflammatory activity of Mesua ferrea Linn flower. Int J Biomed Res. 2012;3:245–52.

Garg S, Sharma K, Ranjan R, Attri P, Mishra P. In vivo antioxidant activity and hepatoprotective effects of methanolic extract of Mesua ferrea linn. Int J Pharmtech Res. 2009;1:1692-6.

Plekratoke K, Boonyarat C, Monthakantirat O, Nualkaew N, Wangboonskul J, Awale S, et al. The effect of ethanol extract from Mesua ferrea Linn flower on Alzheimer’s disease and its underlying mechanism. Curr Issues Mol Biol. 2023;45:4063-79.

Manse Y, Sakamoto Y, Miyachi T, Nire M, Hashimoto Y, Chaipech S, et al. Antiallergic properties of biflavonoids isolated from the flowers of Mesua ferrea Linn. Separations. 2022;9:127.

Diantini A, Subarnas A, Lestari K, Halimah E, Susilawati Y, Supriyatna, et al. Kaempferol-3-O-rhamnoside isolated from the leaves of Schima wallichii Korth. inhibits MCF-7 breast cancer cell proliferation through activation of the caspase cascade pathway. Oncol Lett. 2012;3:1069-72.

Rodríguez P, González-Mujica F, Bermúdez J, Hasegawa M. Inhibition of glucose intestinal absorption by kaempferol 3-O-α-rhamnoside purified from Bauhinia megalandra leaves. Fitoterapia. 2010;81:1220–3.

Mehrbod P, Abdalla MA, Fotouhi F, Heidarzadeh M, Aro AO, Eloff JN, et al. Immunomodulatory properties of quercetin-3-O-α-L-rhamnopyranoside from Rapanea melanophloeos against influenza a virus. BMC Complement Altern Med. 2018;18:184. PubMed PMID: 29903008

Rajurkar N, Hande S. Estimation of phytochemical content and antioxidant activity of some selected traditional Indian medicinal plants. Indian J Pharm Sci. 2011;73:146-51.

Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88-95.

Takomthong P, Waiwut P, Yenjai C, Sripanidkulchai B, Reubroycharoen P, Lai R, et al. Structure– activity analysis and molecular docking studies of coumarins from Toddalia asiatica as multifunctional agents for Alzheimer’s disease. Biomedicines. 2020;8:107. PubMed PMID: 32370238

de Medeiros LM, De Bastiani MA, Rico EP, Schonhofen P, Pfaffenseller B, Wollenhaupt-Aguiar B, et al. Cholinergic differentiation of human neuroblastoma SH-SY5Y cell line and its potential use as an In vitro model for Alzheimer’s disease studies. Mol Neurobiol. 2019;56:7355-67.

Chheng C, Waiwut P, Plekratoke K, Chulikhit Y, Daodee S, Monthakantirat O, et al. Multitarget activities of kleeb bua daeng, a Thai traditional herbal formula, against Alzheimer’s disease. Pharmaceuticals. 2020;13:79. PubMed PMID: 32344916

Takomthong P, Waiwut P, Yenjai C, Sombatsri A, Reubroycharoen P, Lei L, et al. Multi-target actions of acridones from atalantia monophylla

towards Alzheimer’s pathogenesis and their pharmacokinetic properties. Pharmaceuticals. 2021;14:888. PubMed PMID: 34577588

Utari F, Itam A, Syafrizayanti S, Hasvini Putri W, Ninomiya. Isolation of flavonol rhamnosides from Pometia pinnata leaves and investigation of α-glucosidase inhibitory activity of flavonol derivatives. J App Pharm Sci. 2019;9:53–65.

Gella A, Durany N. Oxidative stress in Alzheimer disease. Cell Adh Migr. 2009;3:88–93.

Crespo I, García-Mediavilla MV, Gutiérrez B, Sánchez-Campos S, Tuñón MJ, González-Gallego J. A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells. Br J Nutr. 2008;100:968–76.

Vajragupta O, Toasaksiri S, Boonyarat C, Wongkrajang Y, Peungvicha P, Watanabe H, et al. Chroman amide and nicotinyl amide derivatives: Inhibition of lipid peroxidation and protection against head trauma. Free Radic Res. 2000;32:145-55.

Hasselmo ME. The role of acetylcholine in learning and memory. Curr Opin Neurobiol. 2006;16:710-5.

Xie H, Wang JR, Yau LF, Liu Y, Liu L, Han QB, et al. Catechins and procyanidins of ginkgo biloba show potent activities towards the inhibition of β-amyloid peptide aggregation and destabilization of preformed fibrils. Molecules. 2014;19:5119-34.

Murphy MP, LeVine H. Alzheimer’s disease and the amyloid-β peptide. J Alzheimers Dis. 2010;19:311-23.

Chen G fang, Xu T hai, Yan Y, Zhou Y ren, Jiang Y, Melcher K, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin. 2017;38:1205–35.

Gu L, Guo Z. Alzheimer’s Aβ42 and Aβ40 peptides form interlaced amyloid fibrils. J Neurochem. 2013;126:305-11.

Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc Natl Acad Sci. 2003;100:330–5.

Urbanc B, Cruz L, Yun S, Buldyrev SV, Bitan G, Teplow DB, et al. In silico study of amyloid β-protein folding and oligomerization. Proc Natl Acad Sci. 2004;101:17345–50.

Jiménez-Aliaga K, Bermejo-Bescós P, Benedí J, Martín-Aragón S. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. Life Sci. 2011;89:939-45.

Gilgun-Sherki Y, Melamed E, Offen D. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology. 2001;40:959-75.

Kim GH, Kim JE, Rhie SJ, Yoon S. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol. 2015;24:325-40.

Ofoedu CE, You L, Osuji CM, Iwouno JO, Kabuo NO, Ojukwu M, et al. Hydrogen Peroxide Effects on Natural-Sourced Polysacchrides: Free Radical Formation/Production, Degradation Process, and Reaction Mechanism—A Critical Synopsis. Foods. 2021;10:699. PubMed PMID: 33806060

Downloads

Published

2023-11-10

How to Cite

1.
Plekratoke K, Waiwut P, Yenjai C, Monthakantirat O, Takomthong P, Nualkaew N, Awale S, Chulikhit Y, Daodee S, Khamphukdee C, Boonyarat C. Multi-Target Actions of Flavonoid Derivatives from Mesua ferrea Linn Flower against Alzheimer’s disease Pathogenesis. BSCM [Internet]. 2023 Nov. 10 [cited 2024 Nov. 5];62(4):169-80. Available from: https://he01.tci-thaijo.org/index.php/CMMJ-MedCMJ/article/view/267074

Issue

Section

Original Article